By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Taligen Therapeutics 

Aurora  Colorado    U.S.A.
Phone: n/a Fax: n/a



Start Up

Company News
Alexion Pharmaceuticals Inc. (ALXN) Acquires Taligen Therapeutics for $111 Million and Creates Translational Medicine Group to Accelerate Development of Expanded Portfolio 1/31/2011 7:01:12 AM
Taligen Therapeutics CEO Abbie Celniker Honored with Mass High Tech 2010 All-Star Award 10/29/2010 9:58:44 AM
Taligen Therapeutics Granted Patent for Lead Product Candidate, TT30, and Other Compounds Targeting the Complement System 8/23/2010 8:12:36 AM
Taligen Therapeutics Closes $10 Million Series B Financing Tranche 8/23/2010 7:00:13 AM
Taligen Therapeutics Pipeline Candidates Highlighted at XXIII International Complement Workshop 8/2/2010 8:51:51 AM
Taligen Therapeutics CEO Abbie Celniker Appointed to Massachusetts Life Sciences Center Board of Directors 7/29/2010 12:05:29 PM
Taligen Therapeutics Receives Bioscience Company of the Year Award; CSO Holers Honored with Lifetime Achievement Award 6/23/2010 6:35:28 AM
Taligen Therapeutics Appoints Industry Leader, John Maraganore, as Director 4/15/2010 10:09:35 AM
Taligen Therapeutics Announces Key Additions to Management Team 4/15/2010 10:08:47 AM
Taligen Therapeutics Advances Corporate Growth Plan with Appointment of Jeffrey T. Walsh as Chief Business Officer 12/1/2008 8:59:28 AM